Gyder Surgical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Gyder Surgical is a private, commercial-stage MedTech company developing a novel, pin-less and image-less navigation system for anterior hip replacement procedures. Founded in 2018 and based in San Diego with Australian origins, the company's GYDER® Hip System offers a portable, open-platform technology that integrates into existing surgical workflows, reducing radiation exposure and medical waste. Its primary market opportunity lies in the growing demand for minimally invasive, outpatient joint replacement surgeries, competing against larger, more established navigation and robotic-assisted surgery systems.

Orthopedics

Technology Platform

Pin-less and image-less optical navigation system for orthopedic surgery. Eliminates need for invasive bone pins and pre-operative CT/X-ray imaging. Utilizes real-time tracking and anatomical registration for accurate implant placement.

Opportunities

The rapid shift of joint replacement surgeries to outpatient Ambulatory Surgery Centers (ASCs) creates a strong demand for cost-effective, portable, and efficient surgical technologies like the GYDER system.

Furthermore, the open-platform strategy, which allows use with any implant brand, provides a compelling alternative to closed, proprietary robotic systems, appealing to cost-conscious facilities and surgeon preference.

Risk Factors

Intense competition from large, entrenched medical device companies with substantial sales networks and established robotic platforms poses a significant market penetration challenge.

Additionally, the company must generate robust clinical evidence to drive adoption and secure favorable insurance reimbursement, which is critical for widespread use in cost-sensitive settings.

Competitive Landscape

Gyder Surgical competes in the computer-assisted orthopedic surgery market against major players like Stryker (Mako), Zimmer Biomet (ROSA), Smith & Nephew (CORI), and Johnson & Johnson. These competitors offer integrated robotic and navigation systems, often tied to their own implant portfolios. Gyder's differentiation lies in its non-invasive, image-less approach, open platform, and focus on affordability and simplicity for the ASC setting.

More companies in Digital Health & Biotech SaaS →More companies in United States →